References
- Saito M, Asakura H, Jokaji H, et al. Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapy. Am J Hematol. 1989;32:20–23.
- Homans AC, Rybak ME, Baglini RL, et al. Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia. Jco. 1987;5:811–817.
- Besser MW, MacDonald SG. Acquired hypofibrinogenemia: current perspectives. Jbm. 2016;7:217–225.
- Yokose N, Ogata K, Nakamura K, et al. Hypofibrinogenemia induced by prednisolone therapy in a patient with chronic lymphocytic leukemia complicated with autoimmune hemolytic anemia. Am J Hematol. 1997;55:166–167.
- Fisher M, Lechner K, Hinterberger W, et al. Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with antithymocyte globulin and high-dose methylprednisolone. Scand J Haematol. 1985;34:312–316.
- Miura T, Nakamura M, Tsunematsu Y, et al. Hypofibrinogeneia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy. Acta Paediatr Jpn. 1993;35:148–150.
- Annino L, Goekbuget N, Delannoy A. Acute lymphoblastic leukemia in the elderly. Hematol J. 2002;3:219–223.
- Westbrook CA, Hooberman AL, Spino C, et al. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood. 1992;80:2983–2990.
- Delannoy A, Delabesse E, Lheritier V, et al. Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study. Leukemia. 2006;20:1526–1532.
- Vignetti M, Fazi P, Cimino G, et al. Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) LAL0201-B protocol. Blood. 2007;109:3676–3678.
- Foà R, Vitale A, Vignetti M, et al. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 2011;118:6521–6528.
- Simonovic E, Macukanovic-Golubovic L, Milenovic M, et al. Basic biochemical parameters significant in diagnosis of myeloproliferative diseases. Facta Universitatis, Series Medicine and Biology. 2007;14:82–87.
- Bassan R, Masciulli A, Intermesoli T, et al. Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL). Blood. 2016;128:176.